Medidata vs Saama (2026)
Both put AI across a trial's data work. Medidata's sits inside the platform where the data is captured: Rave anchors it, and Medidata Plus, packaged since July 2026, adds study build that generates forms and edit checks, Clinical Data Studio for data review and safety signals, and the Dot assistant. Saama sits on top of whatever capture systems a sponsor uses, ingesting through more than 40 connectors. Its models draft data queries for reviewer approval, Source to Submission maps data to CDISC SDTM with a confidence score on each mapping, and Clinical AI Agents run from study start to submission. It also sells commercial and provider analytics. A sponsor standardized on Rave gets the AI where the data already lives; a sponsor with a mixed stack gets more from Saama's connectors.
- AI inside the Rave platform, from study build to data review.
- Health Record Connect, bringing patient record data into Rave forms for sites to confirm.
- ISO 27001, 27017, 27018 and 27701 documents on a public trust page.
- More than 40 connectors across a sponsor's existing systems.
- SDTM mapping with a confidence score on every mapping, and drafted queries a reviewer approves.
- Use the company reports in more than 1,500 studies at over 50 sponsors.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Medidata and Saama are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Medidata | Saama |
|---|---|---|
| Primary category | Clinical Trials AI | Clinical Trials AI |
| Headquarters | New York, New York | Campbell, California |
| Website | medidata.com | saama.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Medidata, a Dassault Systemes brand based in New York, sells clinical trial software to drug and device sponsors and contract research organizations. The platform is anchored by Rave electronic data capture and spans study build, trial management, patient experience, imaging and data review, with about 2,300 customers.
Source: AI Health Index, September 2026
Saama, based in Campbell, California, sells a clinical data platform and AI modules to pharmaceutical and biotechnology sponsors and contract research organizations. Smart Data Quality uses models to find data discrepancies and draft queries for reviewer approval, with a generative copilot that writes and tests data quality checks.
Source: AI Health Index, September 2026
Questions buyers ask
How are Medidata and Saama priced and sold?
For Medidata, enterprise agreements with sponsors, contract research organizations and medtech companies are scoped by study count and module. Medidata Plus, launched in July 2026, packages the AI capabilities as one layer the company describes as a predictable investment rather than per-tool costs.
With Saama, enterprise agreements with pharmaceutical and biotechnology sponsors and contract research organizations, sold as platform software and as customized solutions and services, with agents offered as modular additions to a sponsor's existing platforms. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
How do Medidata and Saama handle patient data?
In Medidata's case, the trust and transparency page says the company does not use data for secondary purposes without the customer's explicit written permission, reviews every internal data use request, and runs a Data Collaboration Program in which aggregated, anonymized data sits in a separate environment.
For Saama, the privacy notice (effective 25 Apr 2024) says the company processes pseudonymized trial participant data as a processor for sponsors and contract research organizations, keeps personal information as long as reasonably necessary or as agreed by contract, and may use anonymized data indefinitely. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Which settings and specialties do Medidata and Saama cover?
The platform serves biopharmaceutical and medtech sponsors and contract research organizations across study design, build, execution and closeout, with therapeutic area solutions in oncology, vaccines and CNS; Health Record Connect also feeds Medidata Surgical Planning and real world data work that reaches beyond trials.
In Saama's case, the clinical platform covers sponsor-side development from study design and startup through conduct, biometrics and submission, and the company also sells commercial, medtech and provider-side products (revenue cycle management, care coordination, hospital orchestration) that sit outside the trial scope this listing describes. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
What evidence is published for Medidata and Saama?
For Medidata, the imaging release of May 2026 claims anatomy verification above 97 percent accurate and redaction 32 percent faster, again without method.
With Saama, the home page credits Smart Data Quality with more than 20,000 hours of manual work saved, Patient Insights with 40 percent time savings in patient data review, and the document generator with 30 percent less drafting time. The BRAIN SDTM page says its automation is expected to cut effort by 50 percent and output generation timelines by 69 percent per study. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 29, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers.
Both records were reviewed on this site in September 2026. Neither company publishes a price. Medidata publishes its certification documents; no security attestation was found on Saama's own site.
Ask both how a query or mapping the model drafted is reviewed before it reaches a site.